Wanbury Ltd - WANBURY Share Price

Sector: Pharmaceuticals | ISIN: INE107F01022
₹ 62.60 (1.87%) icon22 Sep, 2023, 3:15:13 PM
Open
₹ 0.00
Prev. Close
₹ 61.45
Turnover(lac)
₹ 2.24
Day's High
₹ 62.65
Day's Low
₹ 62.60
52 Wk High
₹ 70.95
52 Wk Low
₹ 33.30
Book Value
₹ -0.82
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 204.83
P/E
97.29
EPS
0.65
Div. Yield
0.00

Wanbury Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 9/22/2023 3:15:13 PM

    ₹ 62.6 1.15 1.87
  • Open
  • ₹ 0
  • Prev. Close
  • ₹ 61.45
  • Turnover(Lac.)
  • ₹ 2
  • Day's High
  • ₹ 62.65
  • Day's Low
  • ₹ 62.6
  • 52 Week's High
  • ₹ 70.95
  • 52 Week's Low
  • ₹ 33.3
  • Book Value
  • ₹ -0.82
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 204.83
  • P/E
  • 97.29
  • EPS
  • 0.65
  • Divi. Yield
  • 0

Wanbury Ltd Corporate Actions

11 Jul , 2023

12:00 AM

01 Aug , 2023

12:00 AM

01 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

22 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Feb , 2023

12:00 AM

28 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Oct , 2022

12:00 AM

19 Sep , 2022

12:00 AM

AGM

Announcement date: 19 Sep , 2022

View Details

20 Jul , 2023

12:00 AM

BookCloser

View Details

05 Sep , 2023

12:00 AM

BookCloser

View Details

Wanbury Ltd News and Update

Image not found
  • 22 September, 2023 |
  • 8:26 PM

Nirma Ltd. will conduct a required open offer to all public shareholders of GLS in accordance with SEBI regulations.

Article Image
  • IIFL News Service |
  • 22 September, 2023 |
  • 8:26 PM
Image not found
Image not found
  • IIFL News Service |
  • 21 September, 2023 |
  • 8:24 PM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Wanbury Ltd SHAREHOLDING SNAPSHOT
25 September , 2023 | 09:13 AM

PROMOTER - TOTAL39.84%

Indian: 30.59%

Foreign: 9.2462%

NON-PROMOTER - TOTAL 60.16%

Institutions: 0.13%

Non-Institutions: 60.03%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Wanbury Ltd FINANCIALS

Wanbury Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Wanbury Ltd

  • N K Puri
  • Independent Director
  • K Chandran
  • Vice Chairman & Whole Time Dir
  • Jitendra J Gandhi
  • Company Sec. & Compli. Officer
  • Pallavi Shedge
  • Independent Director
  • Binod Chandra Maharana
  • Independent Director
  • Manisha Juvekar
  • Independent Director
  • Anupam Vaidya
  • Independent Director

Summary

Wanbury Ltd is the fastest growing pharma company with a Compounded Annual Growth Rate(CAGR) of 68% over the last 6 years.The company has strong presence in domestic formulations,Active Pharmaceutical Ingredient(API) and Contract Research and manufacturing Services(CRAMS).The company also has its presence in Europe in formulations.Wanbury was incorporated as Pearl Distributors Pvt Ltd in 1990.It went public and was renamed as Pearl Organics Ltd in 1991.The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs.In 1995,Pearl Organics acquired plant of Brij Chemicals Pvt Ltd at Patalganga.In 1996,the company has entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.In 2007,Pharmaceutical Products India Ltd was amalgamated with the company pursuant to the BIFR order.In the same year, Doctors Organics and Chemicals Ltd also came into the fold of Wanbury as this also merged with Wanbury.The company has entered into a strategic association with Bravo Healthcare Ltd and also incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China.The company has opened its office in Zurich,Switzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year... Read More


Reports by Wanbury Ltd


Reports by Wanbury Ltd

Company FAQ

No Record Found